Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Cash flows from operating activities
Net loss	$ (5,528)	$ (14,087)	$ (9,763)	$ (97,610)
Adjustments to reconcile net loss to net cash used in operating activities:
Non-cash interest expense				799
Non-cash debt issuance costs				627
Non-cash stock issuances				577
Stock-based compensation			559	1,018
Fair value of warrants issued				2,301
Loss on extinguishment of debt		224		15,080
Loss on exchange of notes	1,899		1,899
Loss in connection with Share Consideration shares				12,676
Loss in connection with backstop put option liability and fixed maturity consideration			(442)	45,404
Net loss attributable to equity interest in Virion	484		3,302
Change in fair value of Virion contribution liability	180		(240)
Change in fair value of 2023 Convertible Note, SPA Warrant, and the Ayrton Note Purchase Option	126	(570)	1,462	589
Non-cash transaction costs in excess of Business Combination proceeds				7,578
Changes in assets and liabilities:
Prepaid expenses			302
Accounts payable and accrued expenses			1,540	2,038
Accrued expenses - related party			(279)	360
Net cash used in operating activities			(1,660)	(8,563)
Cash flows from financing activities
Payment to Backstop Parties for backstop agreement				(51,606)
Payment to Backstop Parties for Share Consideration				(12,676)
Issuance of common stock pursuant to the backstop agreement and subscription agreement				14,260
Proceeds from Backstop Agreement				1,444
Proceeds from reverse recapitalization				52,070
Proceeds from short-term loans, net of issuance costs			896	8,168
Repayments of short-term loans				(2,100)
Net cash provided by financing activities			896	9,560
Total change in cash and restricted cash			(764)	997
Cash and restricted cash at beginning of period			1,004	34
Cash and restricted cash at end of period	$ 240	$ 1,031	240	1,031
Supplemental disclosure of non-cash financing activities:
Offering costs not yet paid				2,049
Non-cash stock issuances			1,881	15,766
SPA warrant liability upon issuance				$ 1,932